Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $178 from $177 and keeps an Outperform rating on the shares following the ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Quest Diagnostics (DGX) to $180 from $165 and keeps a Neutral rating ...

Following the earnings announcement, Quest Diagnostics (NYSE:DGX)' stock price rose by 0.48% in pre-market trading. The stock ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced positive topline results from the China subpopulation of the global Phase 3 innovaTV 301 ...

Looking to get into virtual reality? Meta Quest 3 represents a significant step forward in virtual reality (VR) and a great starting point for everyone. The new Meta Quest 3S also offers a cheaper ...

HiFi sequencing results from these samples identified an ... a graphical user interface are being optimized to support future diagnostics for all variant types, with the first-tier diagnostic ...

Accelerate expects to announce full-year 2024 financial results in advance of its earnings conference call in March 2025. About Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. is an in vitro ...

Stanford Medicine physicians have a new artificial intelligence tool to assist them when they message patients about test results. The technology drafts an interpretation of clinical test and lab ...

Accelerate expects to announce full-year 2024 financial results in advance of its earnings conference call in March 2025. About Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. is an in ...